• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期血液透析患者的整骨疗法与血清甲状旁腺激素及25-羟胆钙化醇水平(作者译)

[Osteopathy and serum parathormone and 25-hydroxycholecalciferol levels in patients on long-term haemodialysis (author's transl)].

作者信息

Zazgornik J, Kokot F, Pietrek J, Schmidt P, Kopsa H

出版信息

Wien Klin Wochenschr. 1978 Jul 14;90(14):496-9.

PMID:676306
Abstract

Skeletal radiological changes were analyzed in 22 patients treated by chronic haemodialysis. Furthermore, the serum parathormone and 25-hydroxycholecalciferol concentrations were determined. X-ray evidence of renal osteopathy was found in 13 patients (59%). Extraskeletal calcification, subperiostal erosions and cystoids were the predominant lesions. Serum iPTH concentrations were increased in 21 out of 22 haemodialyzed patients. The serum 25-hydroxycholecalciferol concentration was normal. The results of this study seem to indicate that other factors apart from secondary hyperparathyroidism have a share in the development of renal osteopathy in patients on chronic haemodialysis.

摘要

对22例接受慢性血液透析治疗的患者的骨骼放射学变化进行了分析。此外,还测定了血清甲状旁腺激素和25-羟基胆钙化醇浓度。13例患者(59%)有肾性骨病的X线证据。骨外钙化、骨膜下侵蚀和囊肿样变是主要病变。22例血液透析患者中有21例血清iPTH浓度升高。血清25-羟基胆钙化醇浓度正常。本研究结果似乎表明,除继发性甲状旁腺功能亢进外,其他因素也参与了慢性血液透析患者肾性骨病的发生。

相似文献

1
[Osteopathy and serum parathormone and 25-hydroxycholecalciferol levels in patients on long-term haemodialysis (author's transl)].长期血液透析患者的整骨疗法与血清甲状旁腺激素及25-羟胆钙化醇水平(作者译)
Wien Klin Wochenschr. 1978 Jul 14;90(14):496-9.
2
[Surgical aspects of secondary hyperparathyroidism (author's transl)].继发性甲状旁腺功能亢进的外科手术方面(作者译)
Dtsch Med Wochenschr. 1977 Jun 3;102(22):822-6. doi: 10.1055/s-0028-1104971.
3
[Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].[血液透析对慢性肾衰竭患者血液中甲状旁腺激素水平的影响]
Wiad Lek. 1993 Apr;46(7-8):283-5.
4
Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.维持性血液透析的终末期肾衰竭患者甲状旁腺激素与左心室功能及结构的密切关联。
Acta Med Austriaca. 2004 Aug;31(3):67-72.
5
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
6
[Parathyroid hormone and 25-hydroxycholecalciferol concentrations in the serum of patients with kidney transplantations and their radiological correlation].[肾移植患者血清中甲状旁腺激素和25-羟胆钙化醇浓度及其影像学相关性]
Z Gesamte Inn Med. 1978 Aug 1;33(15):516-20.
7
Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.维持性血液透析的终末期肾衰竭患者甲状旁腺激素与左心室功能和结构的密切关联。
J Ayub Med Coll Abbottabad. 2004 Apr-Jun;16(2):3-8.
8
Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy.接受血液透析治疗的糖尿病患者的血糖控制与血清完整甲状旁腺激素水平
Nephrol Dial Transplant. 2008 Jan;23(1):315-20. doi: 10.1093/ndt/gfm639. Epub 2007 Oct 23.
9
Calcitropic hormonal status in north Indian patients with end-stage renal disease.印度北部终末期肾病患者的钙调节激素状态
Natl Med J India. 1999 Sep-Oct;12(5):202-7.
10
RenaGel efficacy in severe secondary hyperparathyroidism.RenaGel对重度继发性甲状旁腺功能亢进的疗效。
Nefrologia. 2002;22(5):448-55.